Advertisement for orthosearch.org.uk
Results 1 - 18 of 18
Results per page:
Bone & Joint 360
Vol. 12, Issue 1 | Pages 5 - 7
1 Feb 2023
Karthikappallil D


Bone & Joint 360
Vol. 12, Issue 6 | Pages 6 - 12
1 Dec 2023
Vallier HA Breslin MA Taylor LA Hendrickson SB Ollivere B


Bone & Joint 360
Vol. 13, Issue 4 | Pages 7 - 9
2 Aug 2024
Monsell F


Bone & Joint 360
Vol. 13, Issue 6 | Pages 7 - 12
1 Dec 2024
Lawniczak D Holley JM Machin JT Hunter JB Briggs TWR Hutton M


Bone & Joint 360
Vol. 13, Issue 5 | Pages 8 - 17
1 Oct 2024
Holley J Lawniczak D Machin JT Briggs TWR Hunter J


Bone & Joint 360
Vol. 11, Issue 3 | Pages 5 - 8
1 Jun 2022
Rigney B


Bone & Joint 360
Vol. 11, Issue 2 | Pages 5 - 10
1 Apr 2022
Zheng A Rocos B


Bone & Joint 360
Vol. 10, Issue 3 | Pages 4 - 5
1 Jun 2021
Page PRJ Poole WEC Handley R


Bone & Joint 360
Vol. 9, Issue 6 | Pages 5 - 11
1 Dec 2020
Sharma V Turmezei T Wain J McNamara I


Bone & Joint 360
Vol. 9, Issue 4 | Pages 6 - 10
1 Aug 2020
Machin JT Forward D Briggs T


Bone & Joint 360
Vol. 8, Issue 5 | Pages 4 - 10
1 Oct 2019
Tsoi K Samuel A Jeys LM Ashford RU Gregory JJ


Bone & Joint 360
Vol. 8, Issue 4 | Pages 5 - 13
1 Aug 2019
Middleton R Khan T Alvand A


Bone & Joint 360
Vol. 6, Issue 3 | Pages 2 - 6
1 Jun 2017
Das A Shivji F Ollivere BJ


Bone & Joint 360
Vol. 2, Issue 6 | Pages 2 - 8
1 Dec 2013
Jones R Wood D

This article provides an overview of the role of genomics in sarcomas and describes how new methods of analysis and comparative screening have provided the potential to progress understanding and treatment of sarcoma. This article reviews genomic techniques, the evolution of the use of genomics in cancer, the current state of genomic analysis, and also provides an overview of the medical, social and economic implications of recent genomic advances.


Bone & Joint 360
Vol. 3, Issue 2 | Pages 2 - 5
1 Apr 2014
Copas DP Moran CG


Bone & Joint 360
Vol. 3, Issue 1 | Pages 7 - 10
1 Feb 2014
Stahel PF

The “Universal Protocol” (UP) was launched as a regulatory compliance standard by the Joint Commission on 1st July 1 2004, with the primary intent of reducing the occurrence of wrong-site and wrong-patient surgery. As we’re heading into the tenth year of the UP implementation in the United States, it is time for critical assessment of the protocol’s impact on patient safety related to the incidence of preventable never-events. This article opens the debate on the potential shortcomings and pitfalls of the UP, and provides recommendations on how to circumvent specific inherent vulnerabilities of this widely established patient safety protocol.


Bone & Joint 360
Vol. 2, Issue 5 | Pages 8 - 12
1 Oct 2013
Phillips JRA

Not all questions can be answered by prospective randomised controlled trials. Registries were introduced as a way of collecting information on joint replacements at a population level. They have helped to identify failing implants and the data have also been used to monitor the performance of individual surgeons. This review aims to look at some of the less well known registries that are currently being used worldwide, including those kept on knee ligaments, ankle arthroplasty, fractures and trauma.


Bone & Joint 360
Vol. 1, Issue 2 | Pages 7 - 10
1 Apr 2012
Field RE Shimmin A Cattani L

The need to demonstrate probity and fair market competition has increased scrutiny of the relationships between orthopaedic surgeons and the industry that supplies them with their tools and devices. Investigations and judgements from the US Department of Justice and the introduction of the AdvaMed and Eucomed codes have defined new boundaries for interactions between these groups. This article summarises the current interplay between orthopaedic surgeons and industry, and provides recommendations for the future.